✦ LIBER ✦
ENCORE: A randomized, controlled, open-label non-inferiority study comparing eliglustat to imiglucerase in Gaucher disease type 1 patients on enzyme replacement therapy who have reached therapeutic goals
✍ Scribed by Cox, Timothy M.; Drelichman, Guillermo; Cravo, Renata; Balwani, Manisha; Burrow, Thomas Andrew; Martins, Ana Maria; Lukina, Elena; Rosenbloom, Barry; Ross, Leorah; Angell, Jennifer; Puga, Ana Cristina
- Book ID
- 122224242
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 50 KB
- Volume
- 111
- Category
- Article
- ISSN
- 1096-7192
No coin nor oath required. For personal study only.